Moreover, we demonstrate that NUAK2 expression is elevated in HG-NMI bladder cancer patients, a clinically challenging group43, and is associated with poor prognosis in aggressive muscle-invasive bladder cancer patients. This evidence concerns the gene NUAK2 and urinary bladder cancer.